Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Prestigious prize goes to researchers who identified B cells and T cells and others who invented the HER2 targeted cancer therapy Herceptin.
Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.
The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research.
Living with cancer and HIV is the theme of this issue.
There is not a significant difference in three-year liver cancer survival rates between people living with HIV and people who are not.
In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
More than 300 organizations call for more funding for the National Institutes of Health.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.